happy 2016
高级会员
- 注册
- 2016-01-12
- 消息
- 1,015
- 荣誉分数
- 356
- 声望点数
- 93
Ottawa Hospital to manufacture COVID-19 vaccine
三种COVID-19疫苗将在渥太华最大的医院生产,用于人体临床试验。渥太华医院宣布其生物疗法生产中心(BMC)将填补加拿大疫苗生产能力的一个关键缺口。邓肯·斯图尔特博士在接受渥太华CTV新闻采访时说:“我认为,我们有能力生产这类产品非常重要,特别是在加拿大流感大流行期间,我们有能力控制疫苗的生产。”生物疗法制造中心将生产的首个Covigenix VAX-001 dna疫苗是艾伯塔省Entos制药公司开发的。Three COVID-19 vaccines will be manufactured at Ottawa's largest hospital for human clinical trials.The Ottawa Hospital announced its Biotherapeutics Manufacturing Centre (BMC) will fill a critical gap in Canada's vaccine manufacturing capacity.
"I think it's very important that we have the capacity to be able to produce these kinds of products, particularly vaccines in the midst of the pandemic in Canada and be able to have control over that production," said Dr. Duncan Stewart in an interview with CTV News Ottawa.
The first COVID-19 vaccine that the Biotherapeutics Manufacturing Centre will produce is a DNA-based vaccine called Covigenix VAX-001, developed by Entos Pharmaceuticals in Alberta.